| Schedule of Loss Per Share of Common Stock |
The following table sets forth the computation of basic and diluted net income (loss) per share of common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30,
|
|
Six Months Ended
September 30,
|
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
|
|
(in thousands, except per share amounts) |
| Basic income (loss) per share: |
|
|
|
|
|
|
|
|
| Numerator: |
|
|
|
|
|
|
|
|
| Net income (loss) |
|
$ |
10,283 |
|
|
$ |
(21,395) |
|
|
$ |
(2,981) |
|
|
$ |
(35,499) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Denominator: |
|
|
|
|
|
|
|
|
| Weighted average common shares outstanding, basic |
|
121,286 |
|
|
109,128 |
|
|
120,979 |
|
|
107,885 |
|
|
|
|
|
|
|
|
|
|
| Basic net income (loss) per common share |
|
$ |
0.08 |
|
|
$ |
(0.20) |
|
|
$ |
(0.02) |
|
|
$ |
(0.33) |
|
|
|
|
|
|
|
|
|
|
| Diluted income (loss) per share: |
|
|
|
|
|
|
|
|
Numerator: |
|
|
|
|
|
|
|
|
| Net income (loss), basic |
|
$ |
10,283 |
|
|
$ |
(21,395) |
|
|
$ |
(2,981) |
|
|
$ |
(35,499) |
|
| Unrealized (gain) loss on derivatives |
|
(2,193) |
|
|
— |
|
|
— |
|
|
— |
|
| Net income (loss), diluted |
|
8,090 |
|
|
(21,395) |
|
|
(2,981) |
|
|
(35,499) |
|
| Denominator: |
|
|
|
|
|
|
|
|
| Weighted average common shares outstanding, basic |
|
121,286 |
|
|
109,128 |
|
|
120,979 |
|
|
107,885 |
|
| Dilutive effect of potential common shares relating to unvested share awards |
|
7,263 |
|
|
— |
|
|
— |
|
|
— |
|
| Dilutive effect of potential common shares from the 2025 Warrants |
|
676 |
|
|
— |
|
|
— |
|
|
— |
|
| Weighted average common shares outstanding, diluted |
|
129,225 |
|
|
109,128 |
|
|
120,979 |
|
|
107,885 |
|
|
|
|
|
|
|
|
|
|
| Diluted net income (loss) per common share |
|
$ |
0.06 |
|
|
$ |
(0.20) |
|
|
$ |
(0.02) |
|
|
$ |
(0.33) |
|
|
|
|
|
|
|
|
|
|
|
| Schedule of Antidilutive Securities Excluded |
Anti-dilutive outstanding securities were excluded from the computation of diluted net income (loss) per share, as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
Six Months Ended
September 30, |
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
| Anti-dilutive outstanding securities |
|
1,195,347 |
|
4,784,947 |
|
8,477,222 |
|
4,770,940 |
|